1[1]Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a maeta - analysis of prospecive studies. JAMA, 1998, 179 (15): 1200.
2[2]Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ, 1997, 314: 180.
3[3]Wong ICK, Mawer GE, Sander JWAS. Severe persistent and visual field constriction associated with vigabatrin - reaction might be dose dependent. BMJ, 1997, 314: 1693.
4[4]Wilton LV, Stephens MD, Mann RD. Visual field defect associated with VGB: observational cohort study. BMJ, 1999, 319:1165.
5[5]World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicenter case - control study. Lancet, 1995,346:1575.
6[6]Conhrane Injuries Group Albumin Reviewers and Chachrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients; systematic review of randomised controlled trials: Why ablumin may not work. BMJ, 1998, 317: 235.
7[7]Funmilayo O. Ajayi, He Sun and Julie Perry. Adverse Drug Reactions: A review of relevant factors. J Clin Pharmacol, 2000, 40:1093.
